Merck issues voluntary recall of cholesterol drug Liptruzet

Merck said it is recalling its combination cholesterol drug Liptruzet, which was introduced in May, because of packaging defects that could reduce effectiveness. In a statement on its website, Whitehouse Station-based Merck said the recall will clear out the entire stock of Liptruzet, which includes all four dose strengths and every batch it has distributed.

Read more about the Liptruzet recall…

0 Responses to “Merck issues voluntary recall of cholesterol drug Liptruzet”



  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s




Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 435 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.


%d bloggers like this: